EPI2ME 23.10-01 Release![Matt Parker]()
Dear Nanopore Community, We are delighted to release a collection of updates and improvements to our…
October 06, 2023
1 min
Published by Author 11
Associate Director, Clinical Bioinformatics
I focus on bioinformatics workflows for clinical applications, ensuring our workflows meet relevant standards.
Expertise
Bioinformatics
Clinical Workflows
Social Media
EPI2ME 23.09-01 Release![Matt Parker]()
Dear Nanopore Community, The Customer Workflows team hope that our users in the northern hemisphere…
September 06, 2023
2 min
Targeted BRCA Gene Analysis with Oxford Nanopore![Matt Parker]()
Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose…
June 19, 2023
4 min
London Calling 2023![Matt Parker]()
As is tradition we wanted to let you know how you can connect with the EPI2ME Labs team both online…
May 11, 2023
2 min
SARS-CoV-2 Midnight Chemistry V14 Update![Matt Parker]()
Introduction Please note
the wf-artic workflow has now been updated to select the Medaka variant…
April 19, 2023
2 min
Importing third-party workflows into EPI2ME Labs![Matt Parker]()
With the release of EPI2ME Labs version 4.0.0 we are now able to run community developed Nextflow…
November 30, 2022
6 min
Page 1 of 2
Information
© 2020 - 2024 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.